Navigation Links
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Date:11/6/2008

f chronic angina. Ranexa may be used with beta blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, and ACE inhibitors.

In the European Union, Ranexa (ranolazine prolonged-release tablets) is indicated as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line anti anginal therapies. CV Therapeutics has granted the Menarini Group an exclusive license to commercialize Ranexa in Europe, among other specified territories.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics Ltd. is the company's European subsidiary based in the United Kingdom.

CV Therapeutics' approved products in the United States include Ranexa(R) (ranolazine extended-release tablets), indicated for the treatment of chronic angina, and Lexiscan(R) (regadenoson) injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. Ranexa(R) (ranolazine prolonged-release tablets) is approved for use in the European Union as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line anti anginal therapies. CV Therapeutics also has other clinical and preclinical drug development candidates and programs.

Except for the historical information contained herein, the matters set forth in this press release, including statements as to research and development and commercialization of products, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
2. FDA Approves Durameds LoSEASONIQUE(R) Oral Contraceptive
3. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
4. FDA Approves Orphan Drug Status for Revolutionary Cancer Drug for Children
5. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
6. FDA Approves Fougeras Clotrimazole Cream USP 1%
7. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
8. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
9. Signalife Board Approves Merger
10. FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
11. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... YORK , July 27, 2015 ... today announced the winners of its annual Klerman ... research by scientists who have been supported by ... career scientists to pursue innovative ideas in neurobiological ... "proof" of concept for the early detection, treatment, ...
(Date:7/26/2015)... ... 26, 2015 , ... Maine Standards Company, LLC is pleased ... kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and Vitamin B12 in a ... recommended “equal delta” method for linearity testing and is liquid, ready-to-use. Simply add ...
(Date:7/24/2015)... Equity Research Institute has initiated ... PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ... Inc. (NASDAQ: NWBO ), and Acorda Therapeutics Inc. ... BioPharma can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI On ... 5,146.41, down 0.49%, the Dow Jones Industrial Average declined ...
(Date:7/24/2015)... , July 24, 2015 ... expected to reach USD 27.8 billion by 2022, growing ... 2022, according to a new study by Grand View ... methodologies is expected to result in significant reduction in ... to augment adoption and usage rates of next generation ...
Breaking Biology Technology:Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 2Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 3Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 4Next Generation Sequencing (NGS) Market To Reach $27.8 Billion By 2022: Grand View Research, Inc. 5
... of digital music recorders, digital cameras and laptops ... 's recent acquisition of ID Technologies Pte Ltd. ... of pressure sensitive die-cut components and labeling products. ... Klotsche, this acquisition, along with previous purchases, will ...
... Since the late 1970s, the problem of storing film from ... an elusive challenge for the medical industry. With some medical ... sharing and archiving medical images on film are fast becoming ... , TeraMEDICA Inc. , a Wauwatosa-based startup with roots in ...
... University Research Park MADISON OpGen, Inc. has ... Ogle and Thomas Pyle. The company is looking to bring ... next level, according to Dan Broderick, managing director of ... lots of experience with company operations and product positioning, Broderick ...
Cached Biology Technology:Brady continues growth through Asian acquisition 2TeraMEDICA offers seamless sharing of digital medical images 2TeraMEDICA offers seamless sharing of digital medical images 3TeraMEDICA offers seamless sharing of digital medical images 4TeraMEDICA offers seamless sharing of digital medical images 5OpGen adds Thomas Pyle and James Ogle to board of directors 2
(Date:7/27/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that Huawei has selected the Synaptics ® ... stylish smartwatch. Huawei chose the state-of-the-art ClearPad capacitive ... and highly responsive human interface qualities such as ... required a classic round watch face and Synaptics ...
(Date:7/27/2015)... ANGELES , July 27, 2015   ... evidence- and experience-based clinical improvement solutions, today announced ... solution is now available on Android smartphones and ... inpatient and post-care organizations can use ZynxCarebook to ... same patient,s condition, streamline care transitions to other ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading ... for its second quarter ended June 30, 2015.  ... million, a decrease of 33% compared to $6.8 million in ... quarter of 2015 was $0.3 million, or $0.01 per diluted ... share, in the same period a year ago.  ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... a cat fancier, you're well aware that hair follicles are ... cat breeder's eye, le chat nu, would quickly succumb in ... ridge of fur down the midback and tail—and needs special ... lab, on the other hand, can be very instructive. Understanding ...
... scientists contributed by invitation to an international scientific ... to identify strategies for the control of the ... locusts stripped fields of crops and trees of ... food supply loss. , Larry Vaughan, associate program ...
... with chronic itching or pain from disfiguring tumors. Infants ... to the brain and other organs. , The disease ... the responsible gene was identified more than a decade ... disease that affects more people than cystic fibrosis, hereditary ...
Cached Biology News:Hirsute Or Hairless? Two Proteins May Spell The Difference 2Hirsute Or Hairless? Two Proteins May Spell The Difference 3Scientists discuss improved biopesticides for locust control in West Africa 2Potential treatments for neurofibromatosis 2Potential treatments for neurofibromatosis 3
... Detergent Clean-up Micro Kit provides a fast and ... Triton X-100 and other detergents from small samples ... Norgens patented protein resin as an ion exchanger. ... g of either acidic or basic protein.A complete ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
... cells form from a hematopoietic stem cells ... to the bone surface and lowering the ... around 4.5. The bone mineral is then ... and function is controlled primarily by Macrophage ...
Values of steady state parameters for enzyme activities are determined....
Biology Products: